Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7T | 9.9T | 9.9T | 8.0T |
Cost of revenue | 6.1T | 8.0T | 7.7T | 6.4T |
Gross profit | 1.6T | 1.9T | 2.2T | 1.7T |
Operating expense | ||||
Research & development | 3.4B | 17.5B | 9.8B | 3.0B |
Selling general and admin | 560.2B | 436.4B | 737.4B | 578.8B |
Other operating expenses | 84.4B | 233.4B | 84.1B | 79.5B |
Operating income | 254.8B | 310.5B | 629.6B | 305.8B |
Non operating interest income | ||||
Income | 39.2B | 98.1B | 19.3B | 65.3B |
Expense | 208.2B | 252.2B | 282.6B | 298.6B |
Other income expense | — | — | — | — |
Pretax income | 101.6B | 185.9B | 351.8B | 63.1B |
Tax provision | 66.1B | 155.7B | 113.8B | 30.5B |
Net income | 35.4B | 30.2B | 238.0B | 32.7B |
Basic EPS | 6 | — | — | — |
Diluted EPS | 6 | — | — | — |
Basic average shares | 6.8B | — | — | — |
Diluted average shares | 6.8B | — | — | — |
EBITDA | 464.0B | 595.5B | 792.2B | 527.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | 7.1B | -30.2B | -19.7B | -3.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |